Multi-level Influences of Alcohol Based Quality and Outcome Measures
酒精质量的多层次影响和结果测量
基本信息
- 批准号:10704144
- 负责人:
- 金额:$ 23.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-13 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAddressAdoptedAdoptionAlcohol consumptionAlcoholsAreaCaringCharacteristicsChronicClinicClinicalCommunitiesDataDecision MakingDependenceDevelopmentDirect CostsDrug abuseDrug usageEffectivenessElectronic Health RecordEmergency department visitEnsureEvidence based practiceFeedbackFetal Alcohol Spectrum DisorderFoundationsFutureGoalsGuidelinesHealth StatusHealth systemHealthcare SystemsIndividualInfluentialsKnowledgeLinkMeasurementMeasuresMedicalMental HealthModelingMonitorNational Committee for Quality AssuranceOutcome MeasurePatientsPerformancePhasePositioning AttributeProductivityPropertyProviderPublic HealthQuality IndicatorQuality of CareReportingResearchSeveritiesStructureSubstance Use DisorderSystemTestingUnited States Centers for Medicare and Medicaid ServicesVariantWashingtonWorkalcohol abuse therapyalcohol and other drugalcohol misusealcohol screeningcare deliverydata visualizationfollow-uphealth care deliveryhigh risk drinkinghospital readmissionimprovedinnovationinsightorganizational structurepreventpreventable deathprototypescreeningsubstance use treatmenttooluptake
项目摘要
Project Summary
Unhealthy use of alcohol remains a critical problem with high-risk drinking increasing by almost 30% between
2001-2002 and 2012-2013. Excessive alcohol use is the third leading cause of preventable death, and is linked
to chronic medical conditions, lost productivity and direct cost to health systems. Evidence-based practices are
available to prevent and treat unhealthy alcohol use and its detrimental consequences. To facilitate uptake of
these practices, health systems use quality measures to identify aspects of care being done well and monitor
areas for improvement. The National Quality Forum has endorsed several care quality measures for unhealthy
alcohol use, which have been adopted for routine decision-making by health systems. These include indicators
for initiation and engagement in treatment for alcohol and other drug (AOD) abuse or dependence (equivalent to
substance use disorder), as well as follow-up after an emergency department visit for AOD abuse or
dependence. Another area proposed for broader adoption is universal screening for unhealthy alcohol use.
Despite adoption of these five measures by health systems, the generalizability of these alcohol-related quality
measures has not been fully established. This includes the lack of knowledge on the expected variability and
reliability of quality measured at different levels of a health system (e.g., clinics, providers). In addition, limited
information exists on the meaningful drivers of improved performance to guide health systems with quality
improvement efforts. This study seeks to address these scientific evidence gaps through the following two
specific aims: 1) examine the variability and reliability of care quality measures for unhealthy alcohol use, and 2)
identify multi-level factors associated with care quality for unhealthy alcohol use. For each of the five quality
measures of focus, hierarchical modeling will be applied to characterize the variability and reliability at four levels
of health care delivery: patient, provider, clinic and community. Hypothesis generating analyses in Aim 2 will
extend hierarchical models from Aim 1 and examine the influence of an expansive set of explanatory variables
conceptually related to receipt of guideline concordant care. Research in all aims will be conducted within the
Kaiser Permanente Washington (KPWA) Health System, which is part of one of the largest nonprofit healthcare
systems in the US. KPWA is an ideal setting given its hierarchical structure and extensive administrative and
electronic health record data to measure quality and multi-level determinants of care quality. Together, scientific
insights gained from this study will provide best practices for the measurement of quality indicators and enhance
reporting tools that disseminate quality information. This will support the study team's long-term goal of
increasing the effectiveness of strategic performance reporting to accelerate efforts to improve care quality for
unhealthy alcohol use. To achieve this goal, the study team will partner with KPWA delivery system leaders to
develop prototype report cards informed by study findings that present the quality performance of providers and
clinics in a manner that is easily interpretable and offer actionable insights.
项目摘要
不健康的酒精使用仍然是一个关键问题,高风险饮酒之间增加了几乎30%
2001-2002和2012-2013。过度使用饮酒是可预防死亡的第三主要原因,并且是联系的
对于慢性医疗状况,生产力失去了卫生系统的直接成本。循证实践是
可用于预防和治疗不健康的饮酒及其有害后果。促进吸收
这些实践,卫生系统采用质量措施来确定护理的各个方面并进行监控
改进领域。国家质量论坛已认可了不健康的几项护理质量措施
饮酒,卫生系统已用于常规决策。这些包括指标
启动和参与酒精和其他药物(AOD)滥用或依赖的治疗(相当于
药物使用障碍),以及急诊科访问AOD滥用或
依赖。提出更广泛采用的另一个领域是对不健康的饮酒的普遍筛查。
尽管通过卫生系统采用了这五项措施,但这些与酒精有关的质量的普遍性
措施尚未完全确立。这包括缺乏有关预期可变性的知识和
在卫生系统的不同水平(例如诊所,提供者)处测量质量的可靠性。另外,有限
有关提高性能的有意义驱动因素的信息,以指导质量的卫生系统
改进工作。这项研究旨在通过以下两个来解决这些科学证据差距
具体目的:1)检查不健康饮酒的护理质量度量的可变性和可靠性,以及2)
确定与护理质量相关的多层次因素,以供不健康的饮酒。对于五个质量中的每一个
焦点,分层建模将应用于四个级别的可变性和可靠性
医疗保健提供:患者,提供者,诊所和社区。在AIM 2中生成分析的假设将
从AIM 1扩展层次模型,并检查一组扩展的解释变量的影响
从概念上讲,与收到指南协调护理有关。所有目标的研究都将在
Kaiser Permanente Washington(KPWA)卫生系统,该系统是最大的非营利性医疗保健之一
美国的系统。鉴于其层次结构和广泛的行政结构,KPWA是理想的环境
电子健康记录数据以衡量护理质量的质量和多层决定因素。在一起,科学
从这项研究中获得的见解将为测量质量指标提供最佳实践并增强
报告传播质量信息的工具。这将支持研究团队的长期目标
提高战略绩效报告的有效性,以加快改善护理质量的努力
不健康的酒精使用。为了实现这一目标,研究团队将与KPWA交付系统领导者合作
开发由研究结果告知的原型成绩单,呈现提供者和
诊所以容易解释并提供可行的见解的方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Edwin Glass其他文献
Joseph Edwin Glass的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Edwin Glass', 18)}}的其他基金
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
- 批准号:
10493961 - 财政年份:2022
- 资助金额:
$ 23.15万 - 项目类别:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
酒精质量的多层次影响和结果测量
- 批准号:
10590820 - 财政年份:2022
- 资助金额:
$ 23.15万 - 项目类别:
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
- 批准号:
10668496 - 财政年份:2022
- 资助金额:
$ 23.15万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
10092143 - 财政年份:2019
- 资助金额:
$ 23.15万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
10349443 - 财政年份:2019
- 资助金额:
$ 23.15万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
9902391 - 财政年份:2019
- 资助金额:
$ 23.15万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
10560538 - 财政年份:2019
- 资助金额:
$ 23.15万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字化治疗:干预措施适应的观察分析
- 批准号:
10652751 - 财政年份:2019
- 资助金额:
$ 23.15万 - 项目类别:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
缩小初级保健中成瘾治疗的参与差距
- 批准号:
9981556 - 财政年份:2017
- 资助金额:
$ 23.15万 - 项目类别:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
缩小初级保健中成瘾治疗的参与差距
- 批准号:
10222485 - 财政年份:2017
- 资助金额:
$ 23.15万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer
创建癌症体细胞变异临床可行性的高质量断言知识库
- 批准号:
10555024 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Accelerated Neuromodulation of Prefrontal Circuitry during Clozapine Treatment
氯氮平治疗期间前额叶回路的加速神经调节
- 批准号:
10726660 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Unified, Scalable, and Reproducible Neurostatistical Software
统一、可扩展且可重复的神经统计软件
- 批准号:
10725500 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
The WUSTL PREP post-bacc program to enhance doctoral readiness in neuroscience
WUSTL PREP post bacc 项目旨在提高神经科学博士的准备程度
- 批准号:
10611674 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别: